Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001104659-23-070410

Options or other derivatives

  • Chief Technology Officer acquired 58,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ROBINSON MATTHEW K · Chief Technology Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-08 Grant or award : show line 1 in the form Stock Option (Right to Buy) +58,000 58,000 D
Loading xslF345X04/tm2318426-9_4seq1.xml…